Ensuring a Robust DNA Analysis and the Best Clinical Interpretation by Generating a High-Quality Data Set

OncoDEEP® Kit enables laboratories to achieve and consistently replicate high-quality sequencing data regarding coverage and sensitivity. Based on analytical performance this Whitepaper assesses the precision of OncoDEEP® Kit while measuring the repeatability and reproducibility.

Combined with a solid BioIT pipeline and clinical interpretation software tools, robust molecular tumor profi ling data enable your lab to successfully identify a broader range of treatment options for patients, all while saving on the costs and burdens associated with outsourcing. By leveraging this innovative technology, labs can streamline the sequencing process, thereby increasing their efficiency as never seen before.

This field is for validation purposes and should be left unchanged.

You may also be interested in these resources

Scientific Application Note

PANCREATIC CANCER: Addition of a PARP inhibitor (veliparib) to gemcitabine + cisplatin chemo did not improve outcomes for patients harbouring germline mutations in BRCA1/2 or PALB2

Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation Journal of Clinical Oncology May 01, 2020 ABSTRACT PURPOSEFive percent to 9% of pancreatic ductal...

Share This